ACM
LLY icon

Ayrshire Capital Management’s Eli Lilly LLY Stock Holding History

Ayrshire Capital Management’s Portfolio LLY Stock Details LLY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.95M Sell
6,630
-76
-1% -$77.7K 3.72% 10
2026
Q1 		$6.17M Sell
6,706
-2,945
-31% -$2.99M 3.19% 15
2025
Q4 		$10.4M Sell
9,651
-75
-0.8% -$71.7K 4.76% 3
2025
Q3 		$7.42M Buy
9,726
+1,134
+13% +$844K 3.44% 9
2025
Q2 		$6.7M Buy
8,592
+765
+10% +$594K 3.22% 16
2025
Q1 		$6.46M Buy
7,827
+145
+2% +$121K 3.13% 16
2024
Q4 		$5.93M Buy
7,682
+256
+3% +$212K 2.89% 17
2024
Q3 		$6.58M Buy
7,426
+732
+11% +$658K 3.13% 14
2024
Q2 		$6.06M Buy
6,694
+69
+1% +$55.2K 3.09% 13
2024
Q1 		$5.15M Buy
6,625
+420
+7% +$299K 2.79% 21
2023
Q4 		$3.62M Buy
6,205
+269
+5% +$157K 2.09% 27
2023
Q3 		$3.19M Buy
+5,936
New +$3.06M 2.06% 26

Other funds holding LLY

Lilly Endowment
Lilly Endowment Indiananapolis, Indiana $108B AUM 53.87% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Ayrshire Capital Management's LLY Position: Q2 2026 in Review

Ayrshire Capital Management reduced its Eli Lilly (LLY) stake by 1.1% in Q2 2026, selling an estimated $77.7K and leaving 6,630 shares worth $7.95M. The position accounts for 3.72% of the portfolio, ranked #10.

Ayrshire Capital Management first reported a position in LLY in Q3 2023 and has held it in 12 quarters since. The position peaked at $10.4M in Q4 2025. 4,597 funds tracked by Wall St. Rank hold LLY as of Q2 2026.

  • Ayrshire Capital Management held 6,630 shares of Eli Lilly worth $7.95M as of Q2 2026.
  • Ayrshire Capital Management sold 76 Eli Lilly shares in Q2 2026, an estimated $77.7K.
  • Eli Lilly made up 3.72% of Ayrshire Capital Management's portfolio in Q2 2026, its #10 holding.
  • Ayrshire Capital Management first reported a position in Eli Lilly in Q3 2023 and has held it in 12 quarters since.
  • Ayrshire Capital Management's Eli Lilly position peaked at $10.4M in Q4 2025.
  • 4,597 funds tracked by Wall St. Rank held Eli Lilly as of Q2 2026.

Based on Ayrshire Capital Management's 13F filing for Q2 2026, filed 14 Jul 2026.